Keith B. Isaacson (1995700)

No ORCID on file · 4 papers in corpus · active 2016

Study types

  • dataset 3
  • article 1

Condition tags

  • endometriosis 4
dataset 2016
Multiplexed Protease Activity\nAssay for Low-Volume\nClinical Samples Using Droplet-Based Microfluidics and Its Application\nto Endometriosis
·doi:10.1021/ja307866z.s005

As principal degrading enzymes of the extracellular matrix,\nmetalloproteinases\n(MPs) contribute to various pathologies and represent a family of\npromising drug targets and biomarker candidates. However, multiple\nproteases and endogenous…

dataset 2016
Multiplexed Protease Activity\nAssay for Low-Volume\nClinical Samples Using Droplet-Based Microfluidics and Its Application\nto Endometriosis
·doi:10.1021/ja307866z.s003

As principal degrading enzymes of the extracellular matrix,\nmetalloproteinases\n(MPs) contribute to various pathologies and represent a family of\npromising drug targets and biomarker candidates. However, multiple\nproteases and endogenous…

article 2016
Multiplexed Protease Activity\nAssay for Low-Volume\nClinical Samples Using Droplet-Based Microfluidics and Its Application\nto Endometriosis
·doi:10.1021/ja307866z.s001

As principal degrading enzymes of the extracellular matrix,\nmetalloproteinases\n(MPs) contribute to various pathologies and represent a family of\npromising drug targets and biomarker candidates. However, multiple\nproteases and endogenous…

dataset 2016
Multiplexed Protease Activity\nAssay for Low-Volume\nClinical Samples Using Droplet-Based Microfluidics and Its Application\nto Endometriosis
·doi:10.1021/ja307866z.s004

As principal degrading enzymes of the extracellular matrix,\nmetalloproteinases\n(MPs) contribute to various pathologies and represent a family of\npromising drug targets and biomarker candidates. However, multiple\nproteases and endogenous…